Protective Effects of Simvastatin, a Lipid Lowering Agent, against Oxidative Damage in Experimental Diabetic Rats
Figure 2
Effect of simvastatin (SMV) and glibenclamide treatment on (a) serum aspartate aminotransferase (AST), (b) alanine aminotransferase (ALT) and (c) total bilirubin in normal and streptozotocin-induced diabetic rats. Data are expressed as means ± SEM (). *Significantly different from control group (). #Significantly different from diabetic-untreated group ().
